AlTi Global (ALTI) Q1 2026 Earnings Transcript

AlTi Global reported Q1 2026 revenue of $73 million, up 28% year over year, with adjusted EBITDA rising 21% to $15 million and AUM increasing 9% to $49 billion. Recurring management and advisory fees grew 16% to $52 million, while investment distributions jumped 75% to $21 million, helped by Zevity's strong performance. Management remains focused on organic growth and cost reduction, but strategic review and restructuring expenses are still elevated and expected to persist into Q2 and possibly Q3.

Analysis

ALTI’s quarter reads less like a clean acceleration in the core business and more like a temporary mix shift toward performance fees masking a still-fragile organic engine. The important signal is that fee revenue is growing, but not fast enough to outrun market-beta sensitivity; that means the equity still trades more like a cyclical asset gatherer than a steady compounding wealth platform. If markets stay constructive, the operating leverage is real, but the base case still depends on converting a volatile AUM backdrop into durable net inflows rather than one-off monetizations.

The second-order issue is timing: strategic-review costs appear to roll off only gradually, so reported earnings likely improve with a lag even if the underlying cost base is already better. That creates a setup where the next two quarters can look deceptively noisy, and consensus may underappreciate how much of the current margin expansion is coming from incentive income rather than repeatable scale economics. In other words, the market may be too focused on headline EBITDA while missing that the cleaner signal is normalized expense trend plus net flow momentum.

The contrarian read is that management’s emphasis on simplification and organic growth is directionally right but probably not enough to re-rate the stock without evidence of sustained fee acceleration. If the external manager incentive stream normalizes, earnings power drops back quickly, so any rally in ALTI should be treated as a trading asset until the company proves it can manufacture growth independent of favorable market dispersion. The upside case is a multi-quarter inflection once review-related drag fades; the downside case is that the business remains trapped between decent headline performance and mediocre repeatability.

Key Decisions for Investors

• Long ALTI for 1-3 months only if shares pull back on any disappointment from strategic-review commentary; use a tight stop because near-term earnings are still fee-mix dependent and can mean-revert quickly.
• Consider a call spread in ALTI 3-6 months out to express a clean upside view on cost roll-off and AUM recovery, rather than outright stock, because the main risk is delayed normalization of expenses.
• Pair long ALTI vs. short a higher-beta wealth/asset-management peer with weaker recurring fee growth over the next quarter; ALTI’s relative setup improves if markets stabilize and performance fees stay elevated.
• If incentive income appears to be peaking, fade the name on strength with a short-term short or put spread; the market is likely to overvalue one quarter of performance-driven distributions.
• For longer-term capital, wait for evidence of organic fee acceleration and lower reported opex before sizing a full position; absent that, the stock remains a tactical trade rather than a core holding.